Akcea therapeutics inc share price

AKCA | Akcea Therapeutics Inc. Profile | MarketWatch Nov 01, 2019 · Akcea Therapeutics, Inc. is a biopharmaceutical company. It engages in the development and marketing of drugs globally to treat patients with rare … AKCA Stock Price | Akcea Therapeutics Inc. Stock Quote (U ... Akcea Therapeutics Inc. Akcea Therapeutics, Inc. is a biopharmaceutical company. It engages in the development and marketing of drugs globally to treat patients with rare and serious diseases Akcea Therapeutics, Inc. Just Recorded A 13% Earnings Beat ... Feb 27, 2020 · Akcea Therapeutics beat revenue and statutory earnings per share (EPS) expectations, with sales hitting US$489m (13% ahead of estimates) and EPS reaching US$0.43 (a 4.3% beat). Akcea Therapeutics, Inc. (AKCA) Stock Price, Quote ...

Jul 19, 2017 · CAMBRIDGE, Mass., July 19, 2017 /PRNewswire/ -- Akcea Therapeutics, Inc. today announced the closing of its initial public offering of 17,968,750 shares common stock at a public offering price of $8.00 per share, including 2,343,750 shares of common stock issued upon full exercise by the underwriters of their option to purchase additional shares. The gross proceeds from the offering …

Akcea Therapeutics Inc (NASDAQ:AKCA) issued its quarterly earnings data on Tuesday, February, 25th. The company reported $0.86 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $2.10 by $1.24. AKCA - Akcea Therapeutics Inc Stock quote - CNNMoney.com Find real-time AKCA - Akcea Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. AKCA Akcea Therapeutics, Inc. Stock Quote Akcea Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing drugs to treat patients with serious and rare diseases in the United States and internationally. The company offers TEGSEDI, which is designed to reduce the production of transthyretin protein.

Akcea, Ionis shares halted premarket for news pending MarketWatch. Friday, March 16, 2018. 08:13 AM ET. Akcea Therapeutics price target raised to $30 from $30 at Stifel MarketWatch. Tuesday, February 27, 2018. 07:33 AM ET. Akcea Therapeutics downgraded to …

Our Commitment At Akcea, we’re on a mission to transform the treatment of unaddressed or under-addressed serious and rare diseases with leading-edge, RNA-targeted medicines. Whether you’re a patient living with a serious condition, or a physician whose patient desperately needs a therapy, we know you’re counting on us, and it fuels our unwavering commitment to … Akcea Therapeutics, Inc. - AKCA - Stock Price & News | The ... Real time Akcea Therapeutics, Inc. (AKCA) stock price quote, stock graph, news & analysis. AKCA | Akcea Therapeutics Inc. Stock Price & News - WSJ